Boundless Bio, Inc.
BOLDNasdaqCIK 1782303HealthcareFiscal year ends Dec 31
Reports and events: 35 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2817:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-374787 |
| 2026-08-0707:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-339093 |
| 2026-06-2308:30 ET | 8-K | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-278570 |
| 2026-06-1710:49 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-273544 |
| 2026-05-0807:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213321 |
| 2026-05-0807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213269 |
| 2026-04-2816:00 ET | DEF 14A | Proxy statementPeriod 2026-06-15 | 0001193125-26-186884 |
| 2026-04-1317:15 ET | 8-K | 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001193125-26-153076 |
| 2026-03-0907:10 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-097543 |
| 2026-03-0907:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-097535 |
| 2025-11-0507:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-265714 |
| 2025-11-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265707 |
| 2025-08-0507:10 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-102391 |
| 2025-08-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-102386 |
| 2025-06-2316:21 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-089002 |
| 2025-05-2316:06 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events | 0000950170-25-076911 |
| 2025-05-0907:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067496 |
| 2025-05-0907:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067495 |
| 2025-04-2916:00 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0000950170-25-060073 |
| 2025-04-0116:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-070496 |
| 2025-03-2707:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-045725 |
| 2025-03-2707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-045722 |
| 2024-12-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-135768 |
| 2024-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123291 |
| 2024-11-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123274 |
| 2024-10-2918:32 ET | SC 13D | Ownership report, active investor | 0001072613-24-000789 |
| 2024-10-1508:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-114466 |
| 2024-08-2017:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-099185 |
| 2024-08-1216:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-095481 |
| 2024-08-1216:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095421 |
| 2024-05-1307:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-058188 |
| 2024-05-1307:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-058186 |
| 2024-04-0216:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-084736 |
| 2024-03-2106:04 ET | S-1/A | Registration statement, amended | 0001193125-24-073230 |
| 2024-03-0616:06 ET | S-1 | Registration statement | 0001193125-24-060708 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:21 ET. Listed shows no prices and gives no investment advice.